SAN FRANCISCO and KIGALI, Rwanda, Nov. 21, 2024 (GLOBE NEWSWIRE) — Bio Usawa and the Rwanda Development Board have partnered to establish Rwanda’s first manufacturing plant for affordable treatments for serious eye diseases like diabetic macular edema. Read here.
Bio Usawa and Rwandan Government Sign a Memorandum of Understanding to Manufacture Affordable Biologics in Africa
Posted in Biosimilars, Drug Development.